Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 14/20 | 0.51 |
| ▸ | MET | P08581 | 1/20 | 0.51 |
| ▸ | ALK | Q9UM73 | 6/20 | 0.44 |
| ▸ | INSR | P06213 | 4/20 | 0.44 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.44 |
| ▸ | IGF1R | P08069 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30860383 | 0.96 | EGFR (0.55) | EGFRMETALKINSRPTK2 | |
| SCHEMBL26906498 | 0.96 | EGFR (0.51) | EGFRMETALKINSRPTK2 | |
| SCHEMBL26906997 | 0.95 | EGFR (0.51) | EGFRMETALKINSRPTK2 | |
| SCHEMBL30860239 | 0.92 | EGFR (0.55) | EGFRMETALKINSRPTK2 | |
| SCHEMBL30860744 | 0.90 | EGFR (0.60) | EGFRMETALKINSRPTK2 | |
| SCHEMBL26906511 | 0.90 | EGFR (0.58) | EGFRMETALKINSRPTK2 | |
| SCHEMBL30860291 | 0.90 | EGFR (0.61) | EGFRMETALKINSRPTK2 | |
| SCHEMBL26906830 | 0.90 | EGFR (0.56) | EGFRMETALKINSRPTK2 | |
| SCHEMBL30860301 | 0.89 | EGFR (0.54) | EGFRMETALKINSRPTK2 | |
| SCHEMBL26906717 | 0.89 | EGFR (0.56) | EGFRMETALKINSRPTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024072075-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2024-04-04 | — | — | WO | claimed |
| WO-2024072075-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2024-04-04 | — | — | WO | disclosed |